Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q78724643)
Watch
English
ICON3 and chemotherapy for ovarian cancer
scientific article published on 01 December 2002
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
title
ICON3 and chemotherapy for ovarian cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
main subject
ovarian cancer
1 reference
based on heuristic
inferred from title
author name string
Robert F Ozols
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
Maurie Markman
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
J Tate Thigpen
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
language of work or name
English
0 references
publication date
1 December 2002
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
volume
360
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
issue
9350
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
page(s)
2086-7; author reply 2088
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
cites work
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911984-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911984-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911984-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911984-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(02)11984-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
PubMed publication ID
12504453
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12504453
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504453%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit